Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis

Tumour hypoxia has been shown to increase mutation rate, angiogenesis, and metastatic potential, and decrease response to conventional therapeutics. Improved tumour oxygenation should translate into increased treatment response. Exogenous recombinant erythropoietin (rEpo) has been recently shown to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hardee, M E, Kirkpatrick, J P, Shan, S, Snyder, S A, Vujaskovic, Z, Rabbani, Z N, Dewhirst, M W, Blackwell, K L
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2005
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361536/
https://ncbi.nlm.nih.gov/pubmed/16288305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602846
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados